Inhibition of HSC70 alleviates hypertrophic cardiomyopathy pathology in human induced pluripotent stem cell‐derived cardiomyocytes with a MYBPC3 mutation

Geahča maid

• Establishment of an induced pluripotent stem cell line (ZJULLi004-A) from a hypertrophic cardiomyopathy patient carrying MYBPC3/c.3764C>A mutation
  Dahkki: Yaxun Sun, et al.
  Almmustuhtton: (2022-10-01)
• Hypertrophic cardiomyopathy mutations in MYBPC3 dysregulate myosin
  Dahkki: Toepfer, C, et al.
  Almmustuhtton: (2019)
• Generation of an induced pluripotent stem cell line (ZJULLi003-A) from a hypertrophic cardiomyopathy patient carrying MYH7/c.4384G > A mutation
  Dahkki: Jingjun Zhou, et al.
  Almmustuhtton: (2022-10-01)
• Metabolic remodeling and calcium handling abnormality in induced pluripotent stem cell-derived cardiomyocytes in dilated phase of hypertrophic cardiomyopathy with MYBPC3 frameshift mutation
  Dahkki: Haruka Mori, et al.
  Almmustuhtton: (2024-07-01)
• How do MYBPC3 mutations cause hypertrophic cardiomyopathy?
  Dahkki: Marston, S, et al.
  Almmustuhtton: (2012)